A potential gain of more than 50% is possible in this medical technology company
A Strategy for Income From Stocks...READ MORE
You're receiving this email because you are subscribed to Options Profits Daily, if you no longer wish to receive these emails you can unsubscribe here.
A Strategy for Income From Stocks
Diabetes mellitus is the epidemic of the century and without effective diagnostic methods at an early stage, diabetes will continue to rise, according to a recent study available from the National institute of Health.
Researchers know that diabetes is a complex disease with a large pool of genes that are involved in its development. The precise identification of the genetic bases of diabetes potentially provides an essential tool to improve diagnoses, therapy (more towards individualized patient targeted therapy) and better effective genetic counseling.
As knowledge of the association between medical genetics and the chronic complications of diabetes advances, researchers may find ways to delay or eradicate these complications that impose an immense pressure on patient's quality of life and the significantly rising cost of health-care services.
But those advances remain in the future and for now, companies are working to treat the disease. One of those companies, as we explain in our latest article, recently reported its latest financial results and the news could result in a significant trading opportunity.
We detail that opportunity which could result in a gain of more than 50% in just a little more than a month. We have the details of the trade and the strategy we use to find the trading opportunity in the article.
There is much more for you to read in our latest free educational article that is available right here...
No comments:
Post a Comment